We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Therapeutic Antibodies – News and Features

A line graph showing the number of trastuzumab claims in the US by month in 2019-2020.

Biosimilar Drugs Are Starting To Bring Competition to the Market, Study Finds

The U.S. biosimilar drug market emerged in 2015 to provide safe, effective and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.
Nanobodies attached to a cell.

Advances in Protein Engineering

In this article, we look at two of the hottest areas in protein engineering for therapeutic applications and how machine learning and artificial intelligence is set to transform the field.
Floating antibodies

Recent Advances in Therapeutic Antibody Screening

This article explores the various screening technologies used in the development of therapeutic antibodies and outlines the recent advances in this area.
An IV bag on a stand.

New Treatment Approach for Rheumatoid Arthritis Shows Promise in Trial

Results of a Phase 2a clinical trial suggest that peresolimab, an antibody that stimulates the human programmed cell death protein 1 (PD-1) pathway, could be a promising new approach for the treatment of rheumatoid arthritis.
Breast cancer cells under a fluorescent microscope.

Breast Cancer Test May Help To Deliver Personalized Therapies

A team led by researchers are coming closer to delivering on the promise of personalized breast cancer therapy with a strategy to predict the most likely response of a cancer to a specific less toxic treatment regimen.
Computer-generated 3D render of some cancer cells.

Small Trial of Cancer-Killing Virus With Immunotherapy Shows Positive Results

Results of a Phase 1/2 clinical trial suggest that oncolytic viral therapy and immunotherapy were safe and improved survival in a subset of patients with recurrent glioblastoma.
White pills spilling out of a purple bottle.

Chemo-Free Drug Combination Beats Chemotherapy for Leukemia Subtype

Research now shows that a chemofree drug-combination therapy is more effective and produces fewer side effects.
A computer-generated 3D render of a brain with multi-colored strands emerging from it.

New Alzheimer’s Drug Slowed Cognitive Decline in Trial, Drugmaker Announces

Pharmaceutical giant Eli Lilly and Company has announced encouraging data from its Phase 3 study of Alzheimer’s drug donanemab, a monoclonal antibody that Lilly claims slowed trial participants’ cognitive decline by 35%.
An IV bag and medical equipment next to a hospital bed.

Combination Treatment for Biliary Tract Cancer Shows Promising Results in Trial

A new clinical trial has found that adding pembrolizumab, an immunotherapy drug, to the current standard treatment for advanced biliary tract cancer can significantly improve patient survival.
Myeloma cells.

Investigational Drug May Improve Stem Cell Transplants for Myeloma

If approved, drug could change standard care.